Latest News-GenScript ProBio Mediaroom_Page

GenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS

SEOUL, South Korea, Oct. 13, 2023 /PRNewswire/ -- Recently, ABL Bio, a partner of GenScript ProBio,...

2023-10-13 09:00 2331

GenScript ProBio Congratulates ABL Bio's IND Clearance of ABL103 Program from MFDS

GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS

NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, an...

2023-03-07 10:00 2338

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global C...

2023-02-22 21:00 2560

A Joint Collaboration Between Bio Immunitas and GenScript ProBio Leads to the Development and Fast Track Manufacturing of A Novel Therapeutic Platform

NANJING, China, Feb. 8, 2023 /PRNewswire/ -- GenScript ProBio, a leading Biologics CDMO to the bio-...

2023-02-08 17:00 1912

GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- Recently, Selecxine, a partner of GenScript ProBio...

2022-12-06 17:14 2880

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a c...

2022-12-05 20:00 1887

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a c...

2022-12-05 20:00 1561

A bispecific antibody molecule jointly developed by Buchang Pharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, received IND clearance from NMPA for clinical trial

NANJING, China, Nov. 29, 2022 /PRNewswire/ -- Buchang Biopharmaceutical and REMD Biotherapeutics, p...

2022-11-29 21:00 2296

GenScript ProBio Signs MOU to Form Strategic Partnership with GeneCraft To Development and Production of New AAV gene therapies

SEOUL, South Korea, Oct. 18, 2022 /PRNewswire/ -- On the Oct 17, 2022, GenScript ProBio (Brian Ho-s...

2022-10-18 08:00 2026

GenScript ProBio Signs MOU to Form Strategic Partnership with GeneCraft To Development and Production of New AAV gene therapies

GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program

NANJING, China, Aug. 23, 2022 /PRNewswire/ -- Recently, Selecxine, a partner of GenScript ProBio, a...

2022-08-23 14:15 2620

GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs

SEOUL, South Korea, July 14, 2022 /PRNewswire/ -- On the July 14, 2022, GenScript ProBio (Brian Ho-...

2022-07-14 13:00 2399

GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs

GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies

SEOUL, South Korea, July 12, 2022 /PRNewswire/ -- On the July 12, 2022, GenScript ProBio (Brian Ho-...

2022-07-13 08:00 2820

GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

NANJING, China, May 12, 2022 /PRNewswire/ -- On the May 12, 2022, GenScript ProBio (Brian Ho-sung ...

2022-05-12 18:26 2358

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again

ZHENJIANG, China, Dec. 7, 2021 /PRNewswire/ -- On December 7th, the "Opening Ceremony ofGenScript P...

2021-12-07 21:33 1860

OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF

NANJING, China, Nov. 17, 2021 /PRNewswire/ -- OncoOne , a biotechnology c...

2021-11-17 22:00 1450

GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea

NANJING, China, Sept. 27, 2021 /PRNewswire/ -- EyeGene's mRNA vaccine against COVID-19, namely "EG-...

2021-09-27 18:35 2146

GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target

NANJING, China, Sept. 26, 2021 /PRNewswire/ -- On September 26, 2021, GenScript ProBio and AskGene ...

2021-09-26 22:28 1942

GenScript ProBio Enters into Agreement with SYNIMMUNE for Manufacturing of their Innovative Antibody Drug

NANJING, China, Sept. 6, 2021 /PRNewswire/ -- GenScript ProBio is delighted to announce the signing...

2021-09-06 16:00 2670

GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII

NANJING, China, June 1, 2021 /PRNewswire/ -- On June 1st 2021, GenScript ProBio and Neoletix (Beiji...

2021-06-01 21:00 1511

SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program

NANJING, China, Feb. 22, 2021 /PRNewswire/ -- On February 21, 2021, GenScript ProBio and SunRock Bi...

2021-02-22 16:54 1740